Magnesium Glycinate
StandardEstablished Evidence. Fully Explained.
Explore the formulation, dosage rationale, evidence behind commonly discussed benefits, and scientific references used to evaluate this Supplesmart product.
Standard Series • Formula Fully Disclosed • Evidence Reviewed • Updated Aug 2026
What's Inside and Why
Supplesmart stands for full clinical disclosure. We provide the exact raw ingredient form, precise elemental dosage, and the direct scientific rationale behind our sourcing.
Why This Form?
Why This Amount?
Full Disclosure
Not Every Claim Has the Same Evidence.
We map active ingredients directly to specific physical claims, classifying the maturity of supporting scientific consensus into transparent tiers.
What We Know
- We strictly reject proprietary blends or hidden active quantities. Every single active molecule and excipient used is quantified and verified by third party testing. You receive pure, clean, completely traceable nutritional chemistry.
- Gentle Gastric Tolerance: Does not act as a strong osmotic laxative, preventing the common discomfort of Magnesium Oxide.
- Regulates Sleep Cycles: Acts as a natural GABA agonist to help down-regulate the nervous system for deeper sleep.
- Relaxes Muscle Fibers: Blocks calcium channels locally to prevent persistent hyperexcitability and cramping.
What We're Still Learning
- Synergy with Melatonin: While co-supplementation is popular, the precise molecular synergetic benefits remain partially quantified.
- Impact on Chronic Stress: Early cortisol correlation models show promise, but definitive systemic human evidence requires broader cohorts.
- Optimal Time of Day: Circadian peak absorption variance is widely theorized, though robust longitudinal timing data is limited.
- Long-term Retention Variance: The retention rate difference between chelated magnesium forms in tissue remains heavily debated in metabolic science.
Evidence Behind the Evaluation
Science Changes. Our Interpretation Can Too.
Scientific progress is dynamic. Our scientific advisory board periodically reviews emerging literature to update clinical evaluation models and adjust product classifications accordingly.
